Doyle Wealth Management Corbus Pharmaceuticals Holdings, Inc. Transaction History

Doyle Wealth Management

  • $1.16 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 05, 2019
SELL
$4.87 - $7.08 $194 - $283
-40 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$6.6 - $7.8 $264 - $312
40 New
40 $0
Q1 2019

May 13, 2019
SELL
$5.76 - $8.95 $230 - $358
-40 Closed
0 $0
Q4 2018

Feb 08, 2019
BUY
$5.26 - $7.97 $210 - $318
40 New
40 $0

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $7.27B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Doyle Wealth Management Portfolio

Follow Doyle Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Doyle Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email